Short Interest in Microbot Medical Inc. (NASDAQ:MBOT) Expands By 80.0%

Microbot Medical Inc. (NASDAQ:MBOT) saw a significant growth in short interest in the month of December. As of December 31st, there was short interest totalling 1,040,000 shares, a growth of 80.0% from the December 15th total of 577,700 shares. Based on an average daily trading volume, of 2,030,000 shares, the short-interest ratio is presently 0.5 days.

Hedge Funds Weigh In On Microbot Medical

A hedge fund recently bought a new stake in Microbot Medical stock. Thoroughbred Financial Services LLC acquired a new position in Microbot Medical Inc. (NASDAQ:MBOT) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 52,250 shares of the biotechnology company’s stock, valued at approximately $53,000. Thoroughbred Financial Services LLC owned approximately 0.33% of Microbot Medical as of its most recent SEC filing. 16.30% of the stock is owned by hedge funds and other institutional investors.

Microbot Medical Stock Performance

NASDAQ:MBOT opened at $1.54 on Wednesday. The stock has a 50-day simple moving average of $1.17 and a 200 day simple moving average of $1.04. Microbot Medical has a 52-week low of $0.82 and a 52-week high of $3.38. The company has a market cap of $26.07 million, a PE ratio of -1.92 and a beta of 1.62.

About Microbot Medical

Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces.